Literature DB >> 23246051

Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings.

Yasuhiro Tsutani1, Yoshihiro Miyata, Takeharu Yamanaka, Haruhiko Nakayama, Sakae Okumura, Shuji Adachi, Masahiro Yoshimura, Morihito Okada.   

Abstract

OBJECTIVE: This study aimed to compare malignant behavior and prognosis between solid tumors and mixed tumors with a ground-glass opacity component on high-resolution computed tomography.
METHODS: We examined 436 of 502 consecutive patients with clinical stage IA adenocarcinoma who had undergone preoperative high-resolution computed tomography and F-18-fluorodeoxyglucose positron emission tomography/computed tomography; 66 patients with tumors with pure ground-glass opacity components were excluded. Tumor type (solid, n = 137; mixed, n = 299) and surgical results were analyzed for all patients and their matched pairs.
RESULTS: In all patients, solid tumors showed a significantly greater association (P < .001) with lymphatic, vascular, and pleural invasion and lymph node metastasis compared with mixed tumors. The disease-free survival was also worse in patients with solid tumors (P = .0006). Analysis of 97 pairs matched for solid component size confirmed that solid tumors were significantly associated with lymphatic, vascular, and pleural invasion (P = .008, P = .029, P = .003, respectively) and poor prognosis. When maximum standardized uptake value and solid component size were matched (n = 79), the differences in pathologic prognostic parameters and disease-free survivals between patients with solid and mixed tumors disappeared.
CONCLUSIONS: Solid tumors exhibit more malignant behavior and have a poorer prognosis compared with mixed tumors, even when the solid component size is the same in both tumor types. However, differences in malignant behavior can be identified using maximum standardized uptake values determined by F-18-fluorodeoxyglucose positron emission tomography/computed tomography.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23246051     DOI: 10.1016/j.jtcvs.2012.11.019

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  25 in total

1.  The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Authors:  Morgan L Cox; Chi-Fu Jeffrey Yang; Paul J Speicher; Kevin L Anderson; Zachary W Fitch; Lin Gu; Robert Patrick Davis; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; David H Harpole; Mark F Berry
Journal:  J Thorac Oncol       Date:  2017-01-08       Impact factor: 15.609

Review 2.  Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy.

Authors:  Hyungjin Kim; Chang Min Park; Jae Moon Koh; Sang Min Lee; Jin Mo Goo
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

3.  Predictors of pathological non-invasive lung cancer with pure-solid appearance on computed tomography to identify possible candidates for sublobar resection.

Authors:  Aritoshi Hattori; Tatsuo Maeyashiki; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-04-22       Impact factor: 2.549

4.  Is volumetric 3-dimensional computed tomography useful to predict histological tumour invasiveness? Analysis of 211 lesions of cT1N0M0 lung adenocarcinoma.

Authors:  Kei Shikuma; Toshi Menju; Fengshi Chen; Takeshi Kubo; Shigeo Muro; Shinji Sumiyoshi; Keiji Ohata; Terumasa Sowa; Takao Nakanishi; Hiroyuki Cho; Shinya Neri; Akihiro Aoyama; Toshihiko Sato; Makoto Sonobe; Hiroshi Date
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-25

5.  The oncological outcomes of segmentectomy in clinical-T1b lung adenocarcinoma with a solid-dominant appearance on thin-section computed tomography.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-10-15       Impact factor: 2.549

6.  Segmentectomy Versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer.

Authors:  Norifumi Tsubokawa; Yasuhiro Tsutani; Yoshihiro Miyata; Yoshinori Handa; Keizo Misumi; Hideaki Hanaki; Eisuke Hida; Morihito Okada
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

7.  Mediastinal lymph node resection in stage IA non-small cell lung cancer with small nodule: is it mandatory?

Authors:  Dong Kwan Kim
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

8.  Extending the survival advantage of ground glass.

Authors:  Fred Lee; Bryan M Burt
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

9.  How to manage patients with subcentimeter non-small cell lung cancer?

Authors:  Tomoyoshi Takenaka
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

10.  Pulmonary adenocarcinomas appearing as part-solid ground-glass nodules: is measuring solid component size a better prognostic indicator?

Authors:  Eui Jin Hwang; Chang Min Park; Youngjin Ryu; Sang Min Lee; Young Tae Kim; Young Whan Kim; Jin Mo Goo
Journal:  Eur Radiol       Date:  2014-10-02       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.